3 Signs Your Team Isn’t Ready for Copilot (Yet)
Why AI becoming a value-driver or a chaos agent hinges on your strategic alignment Like other Microsoft tools that came before it, Copilot could well revolutionize the workplace. Organizations must treat AI rollout differently from starting with Word, and they need to address many factors before diving in. Having technical access to Copilot doesn’t guarantee […]
Shadow AI Is Already in Your Org – Here’s What That Means
Recent surveys are shining a white-hot spotlight on “shadow AI,” and the data is clear: a majority of the world’s engineers, analysts, and other professionals are already using generative AI at work – and are doing so with tools their organizations haven’t approved. Add it all up and you can see the fault lines: AI […]
Why “Personhood” is the AI Cybersecurity Issue Businesses Need to Address Now
Across the many artificial intelligence (AI) developments confronting businesses today, one of the most pressing issues borrows its vocabulary from a philosophical debate: establishing personhood. In this cybersecurity-specific context, “establishing personhood” means being able to accurately differentiate between legitimate, human users and AI-generated bots – and the urgency around getting it right cannot be overstated. Bad actors, armed with AI tools that create hyper-realistic fake identities, are already exploiting companies’ weakness in this area and turning authentication into the ultimate high-stakes battleground.
Taming the Regulatory Beast with AI: Pharma’s Secret Weapon
Explores how AI in regulatory compliance for pharma is transforming the industry, offering practical insights and real-world examples.
Revolutionizing Biopharma with AI Business Solutions: Simplifying Compliance and Development with MSP Expertise
Artificial intelligence (AI) is revolutionizing the biopharma industry, transforming drug discovery, clinical trials, and regulatory processes with unprecedented speed and efficiency. Discover how AI business solutions can streamline your operations, enhance compliance, and propel your organization into the future of pharmaceutical innovation.